Abvc biopharma engages the freemind group to support grant funding

Fremont, ca, may 13, 2022 (globe newswire) -- via newmediawire – abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced it has engaged the freemind group to help abvc explore and identify funding opportunities from non-dilutive sources, such as the nih, dod, nsf, fda and barda, as well as private foundations.
ABVC Ratings Summary
ABVC Quant Ranking